Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | Ulixertinib | 3.16227766 | 0.4101 | 0.04743 |
| HCC1143 | Ulixertinib | 3.16227766 | 0.3418 | 0.02595 |
| HCC1143 | Ulixertinib | 10.0 | 0.0472 | 0.08498 |
| HCC1143 | Ulixertinib | 3.16227766 | 0.5524 | 0.01863 |
| MCF7 | Ulixertinib | 0.01 | 0.9259 | 0.00453 |
| T47D | Ulixertinib | 0.031622777 | 1.0042 | -0.00697 |
| MCF7 | Ulixertinib | 0.003162278 | 1.0595 | -0.00323 |
| HCC1419 | Ulixertinib | 0.003162278 | 0.8790 | 0.00099 |
| MCF7 | Ulixertinib | 0.003162278 | 1.0529 | -0.00099 |
| MCF7 | Ulixertinib | 0.01 | 0.9759 | -0.00097 |
| MCF7 | Ulixertinib | 0.01 | 0.9509 | -0.00122 |
| MCF7 | Ulixertinib | 0.003162278 | 1.0346 | -0.00248 |
| MCF7 | Ulixertinib | 0.031622777 | 0.9175 | 0.00146 |
| MCF7 | Ulixertinib | 0.316227766 | 0.7838 | 0.00034 |
| MCF7 | Ulixertinib | 0.031622777 | 0.7533 | 0.00906 |
| MCF7 | Ulixertinib | 0.031622777 | 0.8924 | 0.00261 |
| MCF7 | Ulixertinib | 0.1 | 0.8389 | 0.02333 |
| MCF7 | Ulixertinib | 0.316227766 | 0.8016 | -0.00077 |
| MCF7 | Ulixertinib | 0.316227766 | 0.5621 | 0.00643 |
| MCF7 | Ulixertinib | 0.1 | 1.0147 | 0.00015 |
| Hs 578T | Ulixertinib | 0.001 | 0.9987 | 0.00368 |
| MCF7 | Ulixertinib | 3.16227766 | 0.4807 | 0.01124 |
| Hs 578T | Ulixertinib | 0.001 | 1.0086 | 0.03848 |
| MDA-MB-157 | Ulixertinib | 0.003162278 | 0.7047 | 0.02507 |
| MDA-MB-157 | Ulixertinib | 0.003162278 | 1.3523 | -0.02381 |